In line with this, it was shown that increased betaglycan expression decreased the invasive behavior of breast cancer cells in vitro in response to TGFβ stimulation and that this effect was abrogated when betaglycan was expressed in a shedding-impaired mutant form (Elderbroom et al., 2014). The gene discussed is TGFBR3; the disease is breast carcinoma.